| Glp-1 receptor agonists in dementia |
2023-6-12 |
2023-9-28 |
|
| glp-1 prodrugs and uses thereof |
2023-5-10 |
2023-7-21 |
|
| Drug delivery system with multipolar magnet and sensor system |
2023-5-09 |
2023-8-31 |
|
| Glucose-sensitive albumin-binding derivatives |
2023-3-28 |
2023-6-08 |
|
| Glp-1 and gip receptor coagonists suitable for oral delivery |
2023-1-09 |
2023-7-07 |
|
| Novel insulin analogues and their uses (div 202201400) |
2023-1-09 |
2023-8-04 |
|
| Mic-1 compounds and use thereof |
2022-12-19 |
2023-7-06 |
|
| Self-righting systems and related components and methods |
2022-11-28 |
2023-3-14 |
|
| Methods for treating il-6 mediated inflammation without immunosuppression |
2022-11-22 |
2023-3-23 |
|
| Rotary dosage sensing module for and in a disposable pen drug delivery device |
2022-11-22 |
2023-3-16 |
|
| Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2- … |
2022-11-16 |
2023-3-23 |
|
| Treatment of diuretic resistance |
2022-9-29 |
2023-1-10 |
|
| Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators |
2022-9-28 |
2022-10-27 |
|
| Semaglutide for use in medicine |
2022-9-20 |
2023-1-26 |
|
| Insulin containing pharmaceutical compositions |
2022-8-19 |
2022-9-22 |
|
| Compositions and uses of glp-1 |
2022-8-19 |
2022-10-31 |
|
| Human CD30 ligand antigen binding proteins |
2022-8-18 |
2022-10-20 |
|
| Injection device with torsion spring and rotatable display |
2022-8-11 |
2022-12-01 |
|
| Novel amylin and calcitonin receptor agonist |
2022-6-22 |
2022-9-06 |
|
| Methods for the purification of proteins using caprylic acid |
2022-6-06 |
2022-10-13 |
|
| Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2- … |
2022-6-03 |
2022-10-06 |
|
| Systems and methods for optimization of bolus timing relative to meal events |
2022-5-13 |
2022-8-23 |
|
| Therapeutic inhibition of lactate dehydrogenase and agents therefor |
2022-5-13 |
2022-12-15 |
|
| Glp-1 receptor agonists in dementia |
2022-5-04 |
2022-9-08 |
|
| Novel acylated insulin analogues and uses thereof |
2022-4-25 |
2022-7-12 |
|
| Compositions of GLP-1 peptides and preparation thereof |
2022-4-13 |
2023-9-19 |
2023-9-19 |
| Improved procoagulant antibodies |
2022-3-25 |
2022-6-07 |
|
| Automatic injection device with a top release mechanism |
2022-3-18 |
2022-8-11 |
|
| Mating factor alpha pro-peptide variants |
2022-3-07 |
2022-6-23 |
|
| Solid compositions comprising a glp-1 agonist, an sglt2 inhibitor and a salt of … |
2022-1-24 |
2022-4-29 |
|
| Process for producing a tablet comprising glp-1 peptides |
2022-1-23 |
2022-3-01 |
|
| Co-Agonist of GLP-1 Receptor and Amylin Receptor |
2021-12-17 |
2023-2-08 |
|
| Safe and invisible cells for the immune system |
2021-12-16 |
2022-4-08 |
|
| Dosing regimen |
2021-12-16 |
2022-5-19 |
|
| Power-efficient accessory device |
2021-12-03 |
2022-3-02 |
|
| Systems and methods for determining insulin sensitivity |
2021-12-03 |
2022-3-15 |
|
| Antibodies and use thereof |
2021-11-19 |
2022-3-03 |
|
| Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet … |
2021-11-19 |
2022-3-03 |
|
| Methods and compositions for the specific inhibition of alpha-1 antitrypsin by … |
2021-11-12 |
2023-3-02 |
|
| Virus Filtration of Liquid Factor VII Compositions |
2021-11-09 |
2022-3-03 |
|
| Novel acylating reagents |
2021-10-29 |
2022-5-05 |
|
| Bispecific antibodies |
2021-10-14 |
2022-5-10 |
2022-5-10 |
| Solid glp-1 derivative compositions for oral administration |
2021-10-08 |
2022-1-20 |
|
| Glucose-sensitive insulin derivatives |
2021-10-01 |
2022-1-17 |
|
| Growth hormones with prolonged in-vivo efficacy |
2021-8-25 |
2021-9-28 |
|
| Compositions comprising a delivery agent and preparation thereof |
2021-8-16 |
2021-12-09 |
|
| Ingestible drug delivery device |
2021-8-09 |
2023-2-01 |
|
| Novel insulin derivatives and medical uses hereof |
2021-8-04 |
2021-11-18 |
|
| Procoagulant antibodies |
2021-7-29 |
2021-11-11 |
|
| Medical injection device with a cleaning chamber |
2021-7-22 |
2021-11-11 |
|
| Syringe device with a dose limiting mechanism and an additional safety … |
2021-7-22 |
2021-11-11 |
|
| Site directed mutagenesis of trem-1 antibodies for decreasing viscosity |
2021-7-20 |
2022-1-13 |
|
| Activating pyruvate kinase r |
2021-6-18 |
2021-10-07 |
|
| Glp-1 compositions and their uses. (request divisional 202000422) |
2021-5-31 |
2021-11-12 |
|
| Drug delivery device |
2021-5-21 |
2021-9-09 |
|
| Drug delivery device with improved dose accuracy |
2021-5-18 |
2021-9-16 |
|
| Tablet formulation comprising a glp-1 peptide and a delivery agent |
2021-5-14 |
2021-9-09 |
|
| Anti-transthyretin antibodies |
2021-5-04 |
2021-12-02 |
|
| Insulins with polar recombinant extensions |
2021-4-20 |
2021-8-12 |
|
| Stabilised Compositions of Factor VII Polypeptides |
2021-4-15 |
2022-2-24 |
|
| Stable compositions of semaglutide and uses thereof |
2021-4-15 |
2021-9-10 |
|
| Pre-Filled Disposable Injection Device |
2021-4-12 |
2021-7-29 |
|
| Human coagulation factor vii polypeptides |
2021-4-12 |
2022-3-10 |
|
| Solid compositions comprising glp-1 agonist, salt of n-(8-(2-hydroxybenzoyl) … |
2021-3-29 |
2021-7-26 |
|
| Automatic actuating mechanism of shifting lever |
2021-3-16 |
2021-11-02 |
2021-11-02 |
| Tablets comprising glp-1 agonist and enteric coating |
2021-3-09 |
2021-6-10 |
|
| An injection device with integrated needles |
2021-2-16 |
2023-3-09 |
|
| Methods of treating autoimmune disease or chronic inflammation with antibodies … |
2021-2-01 |
2021-8-19 |
|
| Bispecific factor VIII mimetic antibody |
2021-1-29 |
2023-3-23 |
|
| Anti-transthyretin antibodies |
2020-12-18 |
2023-4-18 |
2023-4-18 |
| Therapeutic antibodies |
2020-12-18 |
2021-8-05 |
|
| Drug delivery device for delivering a predefined fixed dose |
2020-12-09 |
2022-12-29 |
|
| Fixed dose injection device |
2020-12-09 |
2021-6-24 |
|
| An injection device for delivering a liquid drug |
2020-12-09 |
2022-10-26 |
|
| Process for the manufacture of snac (salcaprozate sodium) |
2020-11-23 |
2021-3-11 |
|
| Egf(a) analogues with fatty acid substituents |
2020-11-17 |
2021-3-04 |
|
| Derivatives of gip and uses of these |
2020-11-12 |
2021-1-29 |
|
| SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2- … |
2020-11-06 |
2022-9-21 |
|
| Solid compositions comprising a glp-1 agonist, an sglt2 inhibitor and a salt of … |
2020-11-06 |
2021-5-14 |
|
| An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human … |
2020-10-27 |
2020-12-25 |
|
| Tolerogenic dna vaccine |
2020-10-23 |
2020-12-25 |
|
| Dose sensing module |
2020-10-08 |
2022-11-17 |
|
| Novel insulin derivatives |
2020-10-07 |
2021-1-28 |
|
| Activating pyruvate kinase r |
2020-9-18 |
2023-9-13 |
|
| Methods and compositions for inhibiting expression of LDHA |
2020-9-16 |
2023-5-30 |
2023-5-30 |
| Housing for a Medical Injection Device |
2020-9-02 |
2020-12-24 |
|
| Pen-type drug delivery device with electronic display on clip member |
2020-8-26 |
2021-1-07 |
|
| Process for the Preparation of Insulin-Zinc Complexes |
2020-8-12 |
2021-3-04 |
|
| Solid compositions comprising an egf(a) derivative and a salt of n-(8-(2- … |
2020-8-07 |
2021-2-11 |
|
| Crystalline polymorphic forms of monosodium n-[-8-(2-hydroxybenzoyl)amino] … |
2020-7-30 |
2022-7-26 |
2022-7-26 |
| Capsule device having improved self-righting ability |
2020-7-22 |
2022-8-25 |
|
| A reactor and method for making calcium hydroxide |
2020-7-08 |
2022-8-11 |
|
| Propylene glycol-containing peptide formulations which are optimal for … |
2020-6-24 |
2020-10-08 |
|
| Ingestible device with delivery member detachment |
2020-6-07 |
2020-12-10 |
|
| Stabilised Solid Compositions of Factor VII Polypeptides |
2020-4-30 |
2020-8-13 |
|
| Growth Hormones with Prolonged In-Vivo Efficacy |
2020-4-28 |
2020-10-01 |
|
| Use of long-acting GLP-1 peptides |
2020-4-16 |
2020-5-07 |
|
| Generation of pancreatic endoderm from stem cell derived definitive endoderm |
2020-4-07 |
2020-10-15 |
|
| Drug delivery device with means for determining expelled dose |
2020-2-27 |
2022-5-05 |
|
| Anti-transthyretin antibodies |
2020-2-12 |
2022-3-08 |
2022-3-08 |